Related Experiment Video
Updated: Aug 16, 2025

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
Published on: October 6, 2023
Comparison Of Cvd Risk Assessment Via Qrisk®2 Vs Reynolds Risk Score In Inflammatory Joint Diseases
Fozia Fatima1, Farzana Hakim2, Umer Ul Haq1
1Department of Rheumatology.
Insights
Rheumatologists should be aware that QRISK®2 and Reynolds Risk Score do not correlate when assessing cardiovascular disease risk in patients with inflammatory joint diseases. This finding impacts routine patient screening protocols.
Area of Science:
- Rheumatology
- Cardiology
- Epidemiology
Background:
- Patients with inflammatory joint diseases face elevated cardiovascular disease (CVD) risk.
- Effective screening tools are crucial for rheumatologists to manage this risk.
- Current screening methods require comparative analysis for accuracy.
Purpose of the Study:
- To compare the performance of QRISK®2 and Reynolds Risk Score in assessing CVD risk.
- To determine the correlation between these two widely used risk assessment tools in a specific patient cohort.
Main Methods:
- A cohort of 401 patients with inflammatory joint diseases was analyzed.
- Cardiovascular disease risk was calculated using both QRISK®2 and Reynolds Risk Score.
- Statistical analysis was performed to assess the correlation between the two scoring systems.
Main Results:
- No significant correlation was observed between the QRISK®2 and Reynolds Risk Score results (p>0.05).
- The findings suggest discordance between the two risk assessment tools in this population.
Conclusions:
- QRISK®2 and Reynolds Risk Score may not be interchangeable for cardiovascular risk assessment in patients with inflammatory joint diseases.
- Further research is needed to validate appropriate screening tools for this high-risk group.
Background:
The risk of cardiovascular disease in patients with inflammatory joint diseases is very high and rheumatologists need to screen their patients for this risk. A number of screening tools have been used in this patient population. Objective was to compare the cardiovascular risk assessment in patients with inflammatory joint diseases using QRISK®2 and Reynolds Risk Score.
Methods:
Four hundred and one patients with inflammatory joint diseases were enrolled via consecutive non probability sampling. Their future cardiovascular disease risk was calculated via the QRISK®2 and Reynolds Risk Scores. The resulting scores were analyzed for any correlation.
Results:
There was no significant correlation between the scores obtain via both risk assessment tools (p>0.05).
More Related Videos
07:44Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Relative Risk
Rheumatic Heart Disease I: Introduction
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Rheumatic Heart Disease III: Medical Management